| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 23 |
| 1 | GABAPENTIN | 21 |
| 2 | CARBOPLATIN | 19 |
| 3 | PREGABALIN | 19 |
| 4 | FENTANYL | 18 |
| 5 | KETOPROFEN | 18 |
| 6 | TAPENTADOL HYDROCHLORIDE | 18 |
| 7 | ABIRATERONE | 17 |
| 8 | ABIRATERONE ACETATE | 17 |
| 9 | BICALUTAMIDE | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CETRORELIX ACETATE | 1 | 0.0016 |
| 1 | KETOPROFEN | 18 | 0.0013 |
| 2 | BICALUTAMIDE | 17 | 0.0011 |
| 3 | SACITUZUMAB GOVITECAN | 3 | 0.0006 |
| 4 | ENTRECTINIB | 1 | 0.0006 |
| 5 | ERGOCALCIFEROL | 16 | 0.0005 |
| 6 | TAPENTADOL HYDROCHLORIDE | 18 | 0.0005 |
| 7 | AVELUMAB | 2 | 0.0005 |
| 8 | ABIRATERONE ACETATE | 17 | 0.0004 |
| 9 | KETAMINE HYDROCHLORIDE | 2 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Microtubule Inhibitor [EPC] | 32 |
| 1 | Platinum-based Drug [EPC] | 28 |
| 2 | RANK Ligand Inhibitor [EPC] | 23 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 18 |
| 4 | Opioid Agonist [EPC] | 18 |
| 5 | Androgen Receptor Inhibitor [EPC] | 17 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 17 |
| 7 | Provitamin D2 Compound [EPC] | 16 |
| 8 | Alkylating Drug [EPC] | 14 |
| 9 | Corticosteroid [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 16 | 0.0005 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 2 | Programmed Death Ligand-1 Blocker [EPC] | 5 | 0.0002 |
| 3 | Androgen Receptor Inhibitor [EPC] | 17 | 0.0002 |
| 4 | Microtubule Inhibitor [EPC] | 32 | 0.0002 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 17 | 0.0002 |
| 6 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 7 | Topoisomerase Inhibitor [EPC] | 10 | 0.0001 |
| 8 | RANK Ligand Inhibitor [EPC] | 23 | 0.0001 |
| 9 | Platinum-based Drug [EPC] | 28 | 0.0001 |